U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C20H24I2O2
Molecular Weight 550.2123
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THYMOL IODIDE

SMILES

CC(C)C1=CC(=C(C)C=C1OI)C2=C(C)C=C(OI)C(=C2)C(C)C

InChI

InChIKey=SHOKWSLXDAIZPP-UHFFFAOYSA-N
InChI=1S/C20H24I2O2/c1-11(2)15-9-17(13(5)7-19(15)23-21)18-10-16(12(3)4)20(24-22)8-14(18)6/h7-12H,1-6H3

HIDE SMILES / InChI

Molecular Formula C20H24I2O2
Molecular Weight 550.2123
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Thymol iodide a dry powder antiseptic; has been used as a substitute for iodoform in skin diseases, wounds, ulcers, etc. It was shown that intrapleural instillation of a slurry of iodized talc (part of which is a thymol iodide) is a safe, adequate, and effective treatment for control of neoplastic or benign pleural effusions.

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
3 gm was instilled into the pleural space through the chest tube
Route of Administration: Intrapleural
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
A51HJM3XSU
Record Status Validated (UNII)
Record Version